The Relationship of Neutrophil Lymphocyte Ratio With Prognosis And Disease Activity In Patients With Rheumatoid Arthritis
Abstract
Keywords
References
- Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet.2016;388:2023-38.
- Tobón GJ, Youinou P, Saraux A. The environment, geo‐epidemiology, and autoimmune disease: rheumatoid arthritis. J Autoimmun. 2010; 35:10‐14.
- Lin YJ, Anzaghe M, Schulke S. Update on the pathomechanism, diagnosis, and treatment options for rheumatoid arthritis. Cells. 2020; 9(4): 880.
- Smolen JS, Breedveld FC, Burmester GR, et al. Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Ann Rheum Dis. 2016; 75(1): 3- 15.
- Orr CK, Najm A, Young F, et al. The utility and limitations of CRP, ESR and DAS28-CRP in appraising disease activity in rheumatoid arthritis. Front Med. 2018; 5: 185.
- Rossaint J, Margraf A, Zarbock A. Role of platelets in leukocyte recruitment and resolution of inflammation. Front Immunol. 2018; 9: 2712.
- Li S, Zou J, Liu C, et al. Baseline derived neutrophil-to-lymphocyte ratio as a prognostic biomarker for non-colorectal gastrointestinal cancer patients treated with immune checkpoint blockade. Clin Immunol. 2020; 212:108345.
- Azab B, Bhatt V, Phookan J,Murukutla S,Kohn N,Terjanian T,Widmann W. Usefulness of the Neutrophil-to-Lymphocyte Ratio in Predicting Short-and Long –Term Mortalty in Breast Cancer Patients.Official Journal of the Society of Surgıcal Onkology 2012;19:217-224.
Details
Primary Language
English
Subjects
Health Care Administration
Journal Section
Research Article
Authors
Gülten Korkmaz
*
0000-0003-4467-9724
Türkiye
Mustafa Özmen
0000-0001-6795-2856
Türkiye
Gerçek Can
0000-0001-8347-0873
Türkiye
Emine Tarhan
0000-0002-2592-1741
Türkiye
Publication Date
December 31, 2022
Submission Date
October 21, 2022
Acceptance Date
December 30, 2022
Published in Issue
Year 1970 Volume: 44 Number: 4